Tumor-associated macrophages (TAMs) are the most common form of immune cell encountered in the tumor microenvironment (TME). In response to environmental stimuli, TAMs exhibit a high degree of plasticity. As an increasing number of TAMs interact with different cytokines in the TME, TAMs undergo a transition from M1-like TAMs to M2-like TAMs. This shift in their characteristics leads to immune suppression and facilitates the progression of the tumor. Reprogramming TAMs to M1-like TAMs will be a promisingly effective strategy in cancer therapy.
Fig.1 M1 and M2-like macrophage roles in tumor formation.1
To boost the development of anti-cancer therapy, Creative Biolabs has successfully developed an affordable and robust drug development service targeting TAM reprogramming. In our drug development service targeting TAM reprogramming, diverse drug types and several targets involved in different pathways are available to support diverse projects from global customers. At the same time, we also provide virus-based TAM reprogramming services for global customers' convenience. At Creative Biolabs, we provide full-around services to help every customer discover novel high-quality therapeutic drugs as well as deliver a useful tool to aid in global customers' projects.
We provide development services for diverse drug types to generate the desirable drugs in accordance with global customers' distinctive demands:
|
|
|
|
|
At the same time, we provide multiple types of targets including but limited to the following to aid in our drug development service targeting TAM reprogramming:
Importantly! We also provide virus-based TAM reprogramming services for global customers' convenience to develop novel anti-cancer drugs.
For more details about our drug development service targeting TAM reprogramming, please feel free to contact us.
Reference
Copyright © 2024 Creative Biolabs. All Rights Reserved.